. Author manuscript; available in PMC: 2010 Jul 1.

Published in final edited form as: Birth Defects Res A Clin Mol Teratol. 2010 Jan;88(1):25–34. doi: 10.1002/bdra.20623

Table 1.

Developmental outcomes following in utero exposure to 20 mg/kg As (V) ^a

Dose	No. of litters (N)	No. of implants (N)	No. of resorptions (%) ^b	No. of birth defects^d (%) ^c	No. of live births (N)
0 (vehicle)	12	108	3 (2.8)	1 (0.95)	102
20 mg/kg	11	100	15 (15)^*	8 (10.2)^*	77

Dams were injected intraperitonially on gd 7 and 8 and the fetuses examined on gd 17.5.

Percent of implants.

Percent from the total number of live born fetuses

Birth defects include NTDs, orofacial abnormalities and gastroschisis.

Significantly different when compared to vehicle treated control animals (p< 0.05).